ReportsnReports.com: Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase

09-Oct-2011 | News-Press Release

GBI Research, the leading business intelligence provider, has released its latest research, “Ophthalmology Therapeutics Market to 2017 – Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market”, which provides insights into the global ophthalmology therapeutics market forecast until 2017. The report provides an in-depth analysis of the six therapeutic indications of ophthalmology, namely glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration. The report also examines the ophthalmology therapeutics treatment usage patterns for the covered indication. In addition, the report includes insights into the ophthalmology R&D pipeline. GBI Research analysis shows that the overall global ophthalmology market for glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration was valued at $10.3 billion in 2010. The market is expected to grow at a CAGR of 3.6% for the forecast period and will reach $13.2 billion by 2017. The global market revenues are expected to increase due to the introduction of new molecules which are currently in the regulatory filing stage and those in the later stages of development.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report also examines global ophthalmology treatment usage patterns and includes insights into the ophthalmology therapeutics R&D product pipeline.
The top pharmaceutical companies in ophthalmology market are Pfizer Inc., Allergan Inc., Alcon Inc, Novartis AG., Merck & co. Inc and Roche. Approximately 70% of the market is covered by these above six companies.

Browse All: Pharmaceuticals Market Research

Scope
• The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration therapeutics market.
• Data and analysis for the global ophthalmology therapeutics market
• Annualized market data for the ophthalmology therapeutics market from 2002 to 2010, with forecasts to 2017
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the global ophthalmology therapeutics market
• Key M&A activities and Licensing Agreements that took place in the ophthalmology therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Align your product portfolio to the markets with high growth potential.
• Develop market entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
• Device a more tailored country strategy through the understanding of key drivers and barriers of the ophthalmology market.
• Develop key strategic initiatives by understanding the key focus areas and leading companies.
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com

http://www.reportsnreports.com

Blog: http://www.reportsnreportsblog.com/

 

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Message
Login to Submit Email

Author Info

Tag Cloud

Categories

More Releases

Comments

Add a Comment

    \n\